Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Morgan Stanley (MS)

Morgan Stanley (MS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 178,579,344
  • Shares Outstanding, K 1,860,589
  • Annual Sales, $ 48,198 M
  • Annual Income, $ 10,996 M
  • 60-Month Beta 1.56
  • Price/Sales 3.44
  • Price/Cash Flow 11.67
  • Price/Book 1.80
Trade MS with:

Options Overview

Details
  • Implied Volatility 25.86%
  • Historical Volatility 26.96%
  • IV Percentile 12%
  • IV Rank 8.00%
  • IV High 43.16% on 10/28/20
  • IV Low 24.35% on 06/11/21
  • Put/Call Vol Ratio 0.53
  • Today's Volume 4,262
  • Volume Avg (30-Day) 50,063
  • Put/Call OI Ratio 1.23
  • Today's Open Interest 740,070
  • Open Int (30-Day) 735,852

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 1.62
  • Number of Estimates 6
  • High Estimate 1.76
  • Low Estimate 1.49
  • Prior Year 1.59
  • Growth Rate Est. (year over year) +1.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
86.95 +11.94%
on 07/08/21
98.39 -1.08%
on 08/02/21
+5.30 (+5.76%)
since 07/02/21
3-Month
82.24 +18.35%
on 05/05/21
98.39 -1.08%
on 08/02/21
+14.69 (+17.78%)
since 05/04/21
52-Week
45.86 +112.23%
on 09/24/20
98.39 -1.08%
on 08/02/21
+48.07 (+97.58%)
since 08/04/20

Most Recent Stories

More News
Presidio Petroleum Closes Inaugural Issuance of Asset Backed Securities

Presidio Investment Holdings LLC ("Presidio Petroleum", "Presidio", or the "Company"), a portfolio company of Morgan Stanley Energy Partners, announced today that it has closed upon the issuance of term...

MS : 97.10 (+0.52%)
ZoomInfo Announces Upsizing of Secondary Offering of Shares of Class A Common Stock

ZoomInfo Technologies Inc. ("ZoomInfo") (NASDAQ:ZI) today announced an upsizing of the previously announced underwritten secondary offering by certain selling stockholders of ZoomInfo, including investment...

MS : 97.10 (+0.52%)
ZI : 58.62 (+3.75%)
ZoomInfo Announces Secondary Offering of Shares of Class A Common Stock

ZoomInfo Technologies Inc. ("ZoomInfo") (NASDAQ: ZI) today announced that certain selling stockholders of ZoomInfo, including investment funds affiliated with TA Associates ("TA"), The Carlyle Group ("Carlyle")...

MS : 97.10 (+0.52%)
ZI : 58.62 (+3.75%)
Tenaya Therapeutics Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced today...

MS : 97.10 (+0.52%)
TNYA : 17.68 (-2.91%)
Reaching Back to Help the Next Generation

--News Direct--

MS : 97.10 (+0.52%)
GoldenTree Announces Closing of $640 Million CLO Under GLM Strategy

/PRNewswire/ -- GoldenTree Loan Management II ("GLM II") and its affiliated investment manager GoldenTree Asset Management (along with other affiliated investment managers "GoldenTree"), announced the...

MS : 97.10 (+0.52%)
Morgan Stanley Investment Management Raises $1.6 billion for North Haven Credit Partners III

Morgan Stanley Investment Management today announced that it has raised $1.6 billion for North Haven Credit Partners III ("NHCP III" or the "Fund"), exceeding its original fundraising target by 29%. Investors...

MS : 97.10 (+0.52%)
Ryvu Therapeutics to participate in upcoming global investor conferences

, /PRNewswire/ -- Ryvu Therapeutics (WSE: RVU), a clinical stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology, announced...

MS : 97.10 (+0.52%)
Cytek Biosciences Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (Nasdaq: CTKB), a leading cell analysis solutions company, announced today that the underwriters of its previously announced initial public offering,...

MS : 97.10 (+0.52%)
CTKB : 26.40 (-0.53%)
Zocdoc Names Edward Liu as Chief Financial Officer

/PRNewswire/ -- , the leading healthcare marketplace, today announced the appointment of as its Chief Financial Officer. The former Head of Americas Technology Banking at Morgan Stanley, and a long-time...

MS : 97.10 (+0.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

MORGAN STANLEY is a preeminent global financial services firm that maintains leading market positions in each of its three primary businesses: securities; asset management; and credit services. The company combines global strength in investment banking and institutionalsales and trading with strength...

See More

Key Turning Points

3rd Resistance Point 99.68
2nd Resistance Point 98.35
1st Resistance Point 97.48
Last Price 97.10
1st Support Level 95.28
2nd Support Level 93.95
3rd Support Level 93.08

See More

52-Week High 98.39
Last Price 97.10
Fibonacci 61.8% 78.33
Fibonacci 50% 72.13
Fibonacci 38.2% 65.93
52-Week Low 45.86

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar